Dimensional Fund Advisors LP Voyager Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $391 Billion
- Q1 2025
A detailed history of Dimensional Fund Advisors LP transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,496,284 shares of VYGR stock, worth $4.73 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,496,284
Previous 1,380,615
8.38%
Holding current value
$4.73 Million
Previous $7.83 Million
35.4%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding VYGR
# of Institutions
120Shares Held
34.8MCall Options Held
12.9KPut Options Held
37.7K-
Armistice Capital, LLC New York, NY5.44MShares$17.2 Million0.28% of portfolio
-
Black Rock Inc. New York, NY5.31MShares$16.8 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$12.4 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$10.1 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.57MShares$8.12 Million0.05% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $122M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...